Bank of Montreal
ONCY

Bank of Montreal’s Oncolytics Biotech ONCY Stock Holding History

Bank of Montreal’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-44,484
Closed -$37.8K – 4000
2026
Q1 		$37.8K Buy
44,484
+6,148
+16% +$6.11K ﹤0.01% 3358
2025
Q4 		$24.4K Buy
38,336
+125
+0.3% +$135 ﹤0.01% 3323
2025
Q3 		$53.5K Sell
38,211
-525
-1% -$588 ﹤0.01% 3107
2025
Q2 		$29.6K Sell
38,736
-432
-1% -$229 ﹤0.01% 3231
2025
Q1 		$21.5K Sell
39,168
-63
-0.2% -$46 ﹤0.01% 3207
2024
Q4 		$36.3K Buy
39,231
+1,307
+3% +$1.36K ﹤0.01% 3167
2024
Q3 		$33.6K Buy
37,924
+499
+1% +$490 ﹤0.01% 3489
2024
Q2 		$38.9K Buy
37,425
+105
+0.3% +$114 ﹤0.01% 3467
2024
Q1 		$38.6K Sell
37,320
-262
-0.7% -$293 ﹤0.01% 3502
2023
Q4 		$51.3K Buy
37,582
+4,937
+15% +$7.72K ﹤0.01% 3555
2023
Q3 		$73.3K Buy
32,645
+265
+0.8% +$647 ﹤0.01% 3354
2023
Q2 		$85.3K Sell
32,380
-2,126
-6% -$3.53K ﹤0.01% 3485
2023
Q1 		$51.6K Sell
34,506
-2,355
-6% -$3.7K ﹤0.01% 3363
2022
Q4 		$67K Hold
36,861
– – ﹤0.01% 3470
2022
Q3 		$50K Buy
36,861
+4,141
+13% +$5.07K ﹤0.01% 3638
2022
Q2 		$34K Sell
32,720
-3,000
-8% -$3.65K ﹤0.01% 3687
2022
Q1 		$58K Buy
35,720
+5,207
+17% +$8.74K ﹤0.01% 3770
2021
Q4 		$43K Buy
30,513
+19,982
+190% +$36.9K ﹤0.01% 3262
2021
Q3 		$22K Sell
10,531
-5,929
-36% -$13.4K ﹤0.01% 3653
2021
Q2 		$46K Buy
16,460
+4,711
+40% +$14.4K ﹤0.01% 3432
2021
Q1 		$54K Sell
11,749
-1,982
-14% -$5.91K ﹤0.01% 3658
2020
Q4 		$37K Buy
13,731
+4,082
+42% +$9.78K ﹤0.01% 4103
2020
Q3 		$19K Buy
9,649
+3,046
+46% +$5.59K ﹤0.01% 3859
2020
Q2 		$13K Sell
6,603
-420
-6% -$791 ﹤0.01% 4043
2020
Q1 		$10K Buy
7,023
+535
+8% +$1.33K ﹤0.01% 3483
2019
Q4 		$31K Buy
6,488
+420
+7% +$474 ﹤0.01% 4063
2019
Q3 		$4K Sell
6,068
-514
-8% -$523 ﹤0.01% 4582
2019
Q2 		$11K Buy
6,582
+793
+14% +$1.44K ﹤0.01% 4489
2019
Q1 		$11K Buy
5,789
+105
+2% +$213 ﹤0.01% 3848
2018
Q4 		$10K Buy
5,684
+841
+17% +$2.28K ﹤0.01% 3890
2018
Q3 		$18K Sell
4,843
-228
-4% -$1.06K ﹤0.01% 3745
2018
Q2 		$28K Buy
+5,071
New +$31.2K ﹤0.01% 3634

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Bank of Montreal's ONCY Position: Q2 2026 in Review

Bank of Montreal sold out of Oncolytics Biotech (ONCY) in Q2 2026, closing a stake of 44,484 shares — an estimated $37.8K sold.

Bank of Montreal first reported a position in ONCY in Q2 2018 and held it in 32 quarters. The position peaked at $85.3K in Q2 2023. 76 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Bank of Montreal reported no remaining Oncolytics Biotech position as of Q2 2026 after selling out during the quarter.
  • Bank of Montreal sold 44,484 Oncolytics Biotech shares in Q2 2026, an estimated $37.8K.
  • Bank of Montreal first reported a position in Oncolytics Biotech in Q2 2018 and held it in 32 quarters.
  • Bank of Montreal's Oncolytics Biotech position peaked at $85.3K in Q2 2023.
  • 76 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.